FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...
A number of research analysts recently issued reports on FENC shares. Stephens upgraded Fennec Pharmaceuticals to a “strong-buy” rating in a research report on Monday, November 18th.
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Fennec Pharmaceuticals (FENC – Research Report) today. The company’s shares closed last Friday at $6.88. See what stocks are ...
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain
Unfortunately for shareholders, while the Fennec Pharmaceuticals Inc. (NASDAQ:FENC) share price is up 38% in the last five years, that's less than the market return. Unfortunately the share price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback